Status:
UNKNOWN
Random Trial for Elderly Patients With NSCLC
Lead Sponsor:
Inje University
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
1. Recently a radomized trial of vinorelbine versus best supportive care in patients at 70 years of age or older demonstrated a definite improvement in overall survival rate and quality of life with c...
Eligibility Criteria
Inclusion
- Patients with pathologically confirmed, advanced(clinical stage IIIB or IV) NSCLC
- No previous chemotherapy history
- Age ≥ 65 years
- ECOG performance status ≤ 2
- Adequate marrow function (ANC ≥ 2,000/mm3, platelet ≥ 100,000/mm3), renal and liver function (total bilirubin \< 2.0 mg/dL, AST/ALT levels \< 3 × the upper limit of normal, serum creatinine \< 2.0 mg/dL)
- Patients with informed written consent
Exclusion
- Patients with other major illness(active infection, severe heart disease, concomitant malignancy, etc)
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00265694
Last Update
December 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University Sanggyepaik Hospital
Seoul, South Korea, 139-707